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Background: Various “risk scores”, mostly based on clinical pt characteristics, predict cardiac events. However, the widely used Syntax Risk Score 
(SRS) is based entirely on angiographic characteristics. While the SRS has proven utility to triage pts to CABG vs. PCI, there is limited data for its use 
as a predictive tool for pts with extensive coronary disease electing to undergo PCI. Therefore, we compared clinical outcomes in pts undergoing PCI 
using the SRS and The New York State Risk Score (NYSRS) - the latter being a clinically orientated risk score.
Methods: Consecutive pts with triple vessel and/or LM disease from Jan 2007 to June 2008 with 1 year MACE (death, MI, TVR) data were studied 
from our single centre PCI registry. The NYSRS and SRS were calculated for all pts and compared to clinical outcomes.
Results: We identified 520 pts (mean age 69 ±12 yrs, 159 females) that fulfilled these criteria. The median risk scores (25-75% Quartile) were 
22 (16,29) (SRS) and 6 (3,10) (NYSRS). Examining outcomes by tertiles of risk score, at 1 yr, the NYSRS was predictive of death (p = 0.0004) and 
MACE (p = 0.003), with the ability of the SRS to predict 1 yr outcomes not reaching statistical significance (p = 0.06 and p = 0.07 respectively). ROC 
analysis was consistent with these findings (Table).
Conclusions: The clinically orientated NYSRS is highly predictive of death and MACE after PCI, outperforming the angiograpically-based SRS. Risk 
prediction models for pts undergoing PCI should incorporate clinical pt characteristics. 
